The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
What is Immune Boost IV Therapy
Our advanced formula features 800 mg L-Carnitine plus 400 mg Alpha Lipoic Acid per serving in Non-GMO and Gluten Free, quick release capsules
Marketed under brand names such as Wegovy and Ozempic, GLP-1 RA drugs first came to market 20 years ago to help people living with Type 2 diabetes manage their blood sugar levels
Non response to B12 injections should therefore necessitate re-evaluation and consideration of other diagnoses